I am clinical study coordinator and assisting therapist for a phase II clinical trial of psilocybin for patients with treatment-resistant depression. I am also the coordinator for a study on the effects of psychedelic use in individuals with bipolar disorder, and the coordinator / lead reviewer for a review and meta-analysis on psychedelic therapies for mental health conditions. I'm committed to studying the therapeutic potential of psychedelics, and I hope to eventually treat people directly, especially those from underserved communities.